The Library of Congress >  Researchers >  Search Finding Aids  >  Frances Oldham Kelsey papers, 1890-2016

Frances Oldham Kelsey papers, 1890-2016

Contact UsHelpSearch All Finding Aids
« Previous Page | Next Page »Part II: Subject File, 1902-2012Navigate Contents List
Access restrictions apply.Some or all content stored offsite.
ContainerContents
Part II: Subject File, 1902-2012 (continued)
BOX II:187 Practolol, 1975, 1996
BOX II:187 Prednisolone, 1968, 1997
BOX II:187 Pregnancy and drug metabolism, 1965-1977, circa 1982, undated
BOX II:188 Pregnancy labeling, 1966-1969, 1975-1983, 1997-2001
BOX II:188 Preludin, drug deformities, 1962, 1973
BOX II:188 Primidone See Containers II:128-II:129, Diphenylhydantoin
BOX II:188 Prison studies/testing, 1968-1983, 1991, 1999-2000
(4 folders)
BOX II:188 Privacy Act/Confidentiality statute
BOX II:188 Bioresearch monitoring, 1974-1984
BOX II:188 Statutory protection for medical records, 1977
BOX II:189 Task Force on Health and Medical Records, 1974-1977
BOX II:189 Procaine with polyvinylpyrrolidone (PVP)
BOX II:189 General, 1968-1987, 1995-2000, undated
BOX II:189 Testimony of Kelsey, 1979
BOX II:189 Progestin and other sex steroids, 1942, 1950-2000, undated
(4 folders)
BOX II:189 Prolactin See Container II:116, Bromocryptine
BOX II:189 Proprandol See Container II:98, Antihypertensives
BOX II:189 Propulsid, 2000-2001
BOX II:189 Prostaglandins, 1970-1973, 1984-1985, undated
BOX II:190 Pruzansky, Samuel, 1954-1960, 1967-1969
BOX II:190 Psychotropic drugs, 1962-1984, 1993-2002, undated
BOX II:190 Public Employees Roundtable, photographic slides, 1984
BOX II:190 Quaaludes, 1972-1980, 1996
BOX II:190 Quackery, 1962-1965, 1975, 1989-1999, undated
BOX II:190 Quinine and quinine drugs, 1954-1956, 1964-1972, 1978-1991, 1996-1999
BOX II:190 Radiation, 1929, 1962-1999, undated
(3 folders)
BOX II:190 Radioactive Drug Research Committees See Container II:134, same heading
BOX II:191 Ratner, Herbert, 1962, 1968, 1996-1999
BOX II:191 Regulatory Affairs Professionals Society, 1980, 1990-1997
BOX II:191 Research Testing Laboratories, Inc., Great Neck, N.Y., transcript of conference, 1993
BOX II:191 Retinoids See Containers II:208-II:209, Vitamin D and Vitamin A
BOX II:191 Review Panel on New Drug Regulation, final report, 1977
BOX II:191 Reye’s syndrome See same container, Salicylates
BOX II:191 Rezulin See Container II:156, Hypoglycemic oral agents
BOX II:191 Rounds, 1972-1981, undated
BOX II:191 Royal Society of Medicine, London, England, 1965-1969, 1989, 1996-1999
BOX II:191 Salicylates, 1959-1985, undated
BOX II:191 Schering Corp. See Container II:142, Flunixin
BOX II:191 Schiffirin, M. J., 1965, 1973, 1984, 1998
BOX II:191 Selenium See Container II:206, Toxicology
BOX II:191 Semustine See Containers II:180-II:182, National Cancer Institute
BOX II:191 Separation of functions, 1980
BOX II:191 Serc (Drug), 1968-1969, 1996, undated
BOX II:191 Serotonin, 1963-1964, 1970, undated
BOX II:191 Shepard, Thomas H., Compendium of Teratogens, 1971, 1996
BOX II:192 Shopsin, Baron, 1991
BOX II:192 Sigma Xi, The Scientific Research Society, U.S. Food and Drug Administration club, 1982-1987, 1996-1997, 2012
BOX II:192 Sjoerdsma, Albert, honorary banquet for, 1989
BOX II:192 Society of Nuclear Medicine, 1960-1973, 1998, undated
BOX II:192 Society of Toxicology, 1964, undated
BOX II:192 Special Survey: Sponsors and Investigators of Clinical Investigations, report on
BOX II:192 1970-1980
(6 folders)
BOX II:192 Undated
(1 folder)
BOX II:193 (1 folder)
BOX II:193 Spermacides/trichamonacides, 1972-1986
BOX II:193 Staff College Executive Committee, 1989-1990
BOX II:193 Stem cells, 2000-2001
BOX II:193 Stolpen, Adam, “Allergic Drug Reactions: Where Does the Duty Lie?” circa 1970, 1997
BOX II:193 Straus, Marc J., 1980-1982, 1996-1997, undated
(4 folders)
BOX II:193 Submission management and review tracking, 1995
BOX II:193 Summers, William K., 1987-1989, 1997-1999, undated
BOX II:193 Supplements, memoranda by Kelsey, 1968
BOX II:194 Suprofen, 1987
BOX II:194 Tamoxifen, report, 1997
BOX II:194 Taussig, Helen B., 1977, 1988, 1994, 2001, undated
BOX II:194 Teplick, Steven K., hearing at U.S. Food and Drug Administration, 1993-1999
BOX II:194 Teratology
BOX II:194 General, 1946, 1960-1962, 1968-1997, undated
(2 folders)
BOX II:194 Screening procedures
BOX II:194 1962-1969
(3 folders)
BOX II:195 circa 1960s
BOX II:195 1970-1995, undated
(9 folders)
BOX II:195 Teratology Society, 1961, 1974, 1984-1988, 1998, 2011, undated
BOX II:196 Tetracyclines/sulfonamides, 1961-1979, undated
BOX II:196 Thalidomide
BOX II:196 Archer, John D., 1960-1979, 1986, 1996-1998, undated
(2 folders)
BOX II:196 Bell, Peter D., “The Thalidomide Case,” 1963, 1995
BOX II:196 Broadsides, “Drug Detective, Frances O. Kelsey, M.D.,” circa 1963 See also Oversize
BOX II:196 Burkholz, Herbert, “Giving Thalidomide a Second Chance,” 1997
BOX II:196 Chick studies, 1962-1969
BOX II:196 CIBA Pharmaceutical Co., 1962, undated
BOX II:196 Cost recovery for thalidomide for sponsor-investigator investigational new drugs, 1996, undated
BOX II:196 Deformities, no evidence of, 1962-1963
BOX II:196 Drug deformities
BOX II:196 Foundation for Medical Research Perinatal Study, Philadelphia, Pa., 1962-1966
BOX II:196 Northrup, Harriett E., 1962
BOX II:197 Epstein, Beryl, and Samuel Epstein, Who Says You Can’t?, 1968
BOX II:197 Exhibits, 1956-1961
BOX II:197 FDA Consumer Memo andFDA Fact Sheet, 1968, 1974
BOX II:197 FDA Dermatological and Ophthalmic Drugs Advisory Committee, 1996-1997
BOX II:197 FDA Thalidomide Working Group
BOX II:197 1961, 1988-1998
(7 folders)
BOX II:198 1999-2001
(4 folders)
BOX II:198 Undated and fragments
BOX II:198 FDA/National Institutes of Health Workshop, “Thalidomide: Potential Benefits and Risks,” 1997
(1 folder)
BOX II:199 (2 folders)
BOX II:199 General
BOX II:199 1960-1979
(6 folders)
BOX II:200 1980-2002, undated
(7 folders)
BOX II:200 Inspection report for SKG #5627, 1962
BOX II:201 Investigation of Trent Busby, 1961-1962
BOX II:201 Isomers and others, 1961-1963, 1970, 1979-1990, undated
(2 folders)
BOX II:201 Kevadon
BOX II:201 Memoranda, 1960-1962
(3 folders)
BOX II:201 Microfiche of documents from unapproved new drug applications 12611 and 12711 (thalidomide) obtained through Freedom of Information Act request of John Carey, 1978
Microfiche shelf no. 22,656
BOX II:201 Telephone calls, 1962-1963
(2 folders)
Next Page »

Contents List